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PREVALENCE OF DEPRESSION IN PATIENTS WITH 
MIGRAINE, A CROSS-SECTIONAL STUDY FROM A 
TERTIARY CARE HOSPITAL
Zuhaib Ahmed1, Umar Farooque2, Aijaz Ali3, Syeda Urooj Riaz4, Farah Yasmin5, Muhammad Ramzan6, Vijaya Chaitanya Bollampally7, 
Ehtesham Zahoor8, Omer Cheema9, Mujeeb Ur Rehman10, Rizwan Farooque11, Muhammad Daim Bin Zafar12
BACKGROUND
Headache is one of the most common presenting complaints in patients attending primary care centers and the 
majority of them have primary headache syndromes. Depressive disorders are among the leading causes of disability 
globally and can further complicate the clinical manifestation if coupled with other comorbidities. Therefore, the 
primary objective of our study was to determine the prevalence of depression in migraine patients presenting at a 
tertiary care hospital to better understand the leading causes of the disease.
METHODS
A cross-sectional study was carried out between December 2019 and June 2020 (six months) including 66 migraine 
patients between 18 and 45 years of age presenting to the neurology outpatient clinics at a tertiary care hospital in 
Karachi, Pakistan. Non-probability convenience-based sampling technique was used to calculate the sample size, and 
the data was collected via face-to-face interviews. The first section of the questionnaire consisted of 
socio-demographic factors such as age, gender, educational, occupational, and marital status in addition to the clinical 
characteristics such as the duration of the disease and the frequency of migraine attacks. The second section 
assessed the depressive symptoms of the participants using the Patient Health Questionnaire-9 (PHQ-9) and any 
patient with a score of five or more was considered as suffering from a depressive disorder. All statistical analysis was 
conducted using Statistical Package for Social Sciences (SPSS) version 23.0.
RESULTS
Out of a total of 66 participants, almost two-third (n=43, 65.2%) were males, while nearly one-third (n=23, 34.9%) 
were females. The average age of the patients was 27.59±5.37 years. The frequency of depression was observed in 
approximately three-quarters (n=49, 74.2%) of the migraine patients in our study. The prevalence of depression was 
only significantly associated with disease duration (p=0.027) and the number of migraine attacks (p=0.015).
CONCLUSION
In conclusion, the prevalence of depression was found to be significantly high among migraine patients, therefore 
migraine might be related to depression. Depression should not be ignored while evaluating migraine subjects for good 
prognosis and management of the disease.
KEYWORDS migraine, psychiatric disorders, depression
INTRODUCTION
Migraine is a chronic neurological disorder that is 
characterized by pulsating headache (i.e. feeling of 
fullness over the forehead) that occurs in recurrent 
attacks and is often unilateral [1]. It can be 
accompanied by other clinical manifestations including 
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nausea, vomiting, vertigo, photophobia, and 
phonophobia (i.e. sensitivity of light and sound) [1, 2]. It is 
classified as the third most common disease with an 
estimated prevalence of 14.7% globally [3]. It is ranked 
as the seventh most disabling disorder worldwide 
responsible for 2.9% of all years of life lost to disability 
[1, 3].
 
Depression comprises symptoms of feeling 
melancholic, lack of spirit, loss of enjoyment, changes 
in appetite, sleep, and low energy resulting in increased 
lethargy lasting for two weeks [4]. Clinically significant 
depression is associated with low quality of life and has 
been recognized as the major contributor to suicide and 
disability burden globally by the World Health 
Organization (WHO) [4, 5].
A bi-directional association seems to exist between 
depression and migraine, with each disorder enhancing 
the possibility of the other [6]. Published literature 
suggests rates of psychiatric comorbidity to range 
between 69% and 87% among migraine patients [7, 8]. 
The findings of a pooled meta-analyses reported that 
depression is nearly two times more frequent in 
subjects with migraine than in people unaffected by 
headache [9]. Another study conducted in England 
demonstrated a relationship between migraines and 
affective disorders, particularly depression [10]. Lastly, a 
study carried out in Taiwan demonstrated greater than 
three-quarters (78%) of the population with 
transformed migraine have psychiatric comorbidity with 
more than half (57%) suffering from major depression [11].
Psychiatric comorbidity such as depression complicates 
the management of migraine patients and results in 
poor prognosis. The mechanisms underlying migraine 
are reported to be highly complex and a wide 
heterogeneity exists with a proportion of the population 
being fully functional while others experiencing serious 
disabilities such as encountering social, affective, and 
occupational limitations. Much of this heterogeneity is 
accounted for by the presence of comorbidities 
including psychiatric illnesses [9]. Hence, the primary 
objective of this study was to determine the frequency 
of depression in migraine patients presenting to the 
neurology department in our part hospital. A secondary 
aim was to determine the impact of socio-demographic 
and clinical factors on the observed depression 
prevalence in migraine patients.
METHODS
STUDY SETTING AND DESIGN
This was a cross-sectional study conducted between 
December 2019 and June 2020. Over six months’ 
duration at the neurology out-patient clinic of a tertiary 
care hospital in Karachi, Pakistan.
Sample size, inclusion and exclusion criteria
Non-probability convenience-based sampling 
technique was used to calculate the sample size of 66 
patients. The sample population included all patients 
between 18-45 years of age and either gender (i.e. 
male or female) having a history of migraine headache 
of two months’ duration. All patients were labeled as 
having depression as per operational definition. 
However, we excluded all individuals already taking 
anti-depressant medications. We also excluded all 
patients with major medical disorders including 
diabetes, myocardial infarction, and hypertension (as 
per medical record). Ethical approval was obtained 
from the Institutional Review Board.
SAMPLING TECHNIQUE AND DATA COLLECTION
All data were collected via an 
interviewer-administered-questionnaire. The principal 
investigator explained the purpose and the 
methodology of the study to all migraine patients. 
Those migraine patients who agreed to participate were 
also asked to give both verbal and written informed 
consent before their inclusion in the study. A 
well-standardized two-section questionnaire was 
designed to collect data for this study. The first section 
of the questionnaire was based on the participant's 
socio-demographic characteristics including gender, 
age, educational, occupational, monthly income, and 
marital status in addition to the clinical factors such as 
duration of the disease and the frequency of migraine 
attacks. The second section consisted of questions 
about the Patient Health Questionnaire-9 (PHQ-9) [12] 
utilized to assess the frequency of depression among 
migraine patients based on recommended duration 
(two weeks) and scores mentioned as follows: mild 
depression (a score of 5-9), moderate depression (a 
score of 10-14), moderately severe (a score of 15-19) 
and severe depression (a score of 20 or above). 
Depressive disorder was labeled as positive for a score 
of ≥5 otherwise it was labeled as negative. The 
questionnaire was also reviewed by two senior 
neurologists for validity and reliability (reliability index 
0.85).
STATISTICAL ANALYSIS
All statistical analysis was performed using Statistical 
Package for Social Sciences (SPSS) version 23.0. 
Frequencies and percentages were computed for 
categorical variables like sex, marital status, education 
status, occupation status, monthly income, and 
depression. Mean and standard deviations were 
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computed for continuous variables like age and 
duration of illness. Effect modifiers like age, sex, 
duration of illness, marital status, education status, 
occupational status, and socioeconomic status were 
controlled through stratification by applying Chi-square 
and Fischer's exact test. A p-value of≤0.05 was 
considered statistically significant.
RESULTS
SOCIO-DEMOGRAPHIC AND CLINICAL 
CHARACTERISTICS OF THE PARTICIPANTS
A total of 66 migraine patients participated in this 
study. The mean age of the patients was 27.59±5.37 
years. The median duration of the migraine disease in 
our sample population was two [interquartile range 
(IQR)=1] months while the median number of migraine 
attacks was 3 (IQR=1).
Nearly three-fifth (n=39, 59.1%) of our sample 
population were males while (n=27, 40.9%) were 
females. Nearly two-third (n=43, 65.2%) of patients 
were married while (n=23, 34.8%) were unmarried. 
The highest proportion of migraine patients in our study 
were graduates (n=26, 39.4%) followed by (n=11, 
16.7%) in intermediate level, while equal proportions of 
our participants were not formally educated and 
received secondary degrees (n=8, 12.1%). Equal 
proportions received primary and master degrees 
(n=6, 9.1%). The highest proportion of participants in 
our survey were privately employed (n=30, 45.5%) 
followed by government employees (n=13, 19.7%) 
and industrial workers (n=14, 21.2%). Half of the 
patients (n=33, 50.0%) earned a monthly income of 
less than 30,000 rupees, followed by (n=31, 46.9%) 
earned between 31,000 and 70,000 rupees, while a 
very minor proportion (n=2, 3.03%) earned greater 
than 70,000 rupees (Table 1).
Table 1: Sociodemographic characteristics of the 
participants
Prevalence of depression among the participants 
and its association with socio-demographic and 
clinical factors
Nearly three-quarters (n=49, 74.2%) of our 
participants were suffering from depression as 
determined using the PHQ-9 questionnaire, as 
illustrated in Figure 1.
Figure 1: Prevalence of depression in migraine 
patients
The highest prevalence of depression (n=28, 57.1%) 
was observed in patients aged 26-30 years, however, 
this did not reach statistical significance (p=0.708). 
Depression was more common in male patients 
(n=27, 55.1%) in comparison to females (n=22, 
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44.9%), however, the difference was not statistically 
significant (p=0.263). Furthermore, depression was 
not significantly associated with the marital status of 
the patients (p=0.525).
In contrast, depression was significantly associated 
with the disease duration (p=0.027) as nearly 
three-quarters (n=37, 75.5%) of the depressed 
participants had a disease duration of two to three 
months while only a quarter (n=12, 24.5%) of 
migraine patients that had depression reported a 
disease duration of greater than three months. 
Depression was also significantly associated with the 
number of migraine attacks (p=0.015) as a greater 
proportion (n=36, 73.5%) of patients that had 
depression experienced two to three migraine attacks 
in comparison to those with four to five migraine 
attacks (n=13, 26.5%) (Table 2).
Table 2: Association of socio-demographic and 
clinical characteristics with a prevalence of 
depression in migraine patients
DISCUSSION
Our results report a high prevalence of depression 
amongst patients with Migraines. These migraine 
attacks are also reported to be associated with nausea 
and changes in vision. This neurological disorder affects 
the quality of life (QOL) of an individual and results in 
significant loss of productivity [13, 14]. The proportion of 
the migraine burden is contributed by the coexisting set 
of psychiatric disorders namely depression, anxiety, 
phobias, and panic attacks. Breslau and his colleagues 
in their study demonstrated this relationship between 
migraine and depression by reporting a three-fold 
increased risk of depression in migraine patients 
compared to non-migraine ones while those who had 
depression without a previous history of migraine were 
also three times more likely to develop migraine 
compared with non-depressed patients
[15]. Studying the relationship between migraine and 
depression is essential for diagnosis and management.
This cross-sectional study comprised 66 patients 
presenting with migraine headaches with a mean age 
of 27.59±5.37 years with most of the patients 
between 26 and 30 years of age. The onset of migraine 
occurs from childhood being more prevalent between 
20-30 years and declining after 40 years of age. 
Hence, the prevalence increases from the first to fourth 
decades and declines thereafter [16]. Migraines are 
reported to be precipitated by multiple environmental 
and genetic factors with nearly two-thirds of cases 
having a familial association [17]. Additionally, women 
are three times more susceptible to migraine attacks 
compared to men and this difference is reported to be 
hormonally-driven [18, 19]. Nearly 18% of women and 6% 
of men suffer a migraine annually, with a lifetime risk of 
43% and 18% respectively in the United States [17]. In 
Europe, 12-28% of people get affected by migraine 
once in their lifetime with about 14-35% of adult 
women and 6-15% of adult men getting at least once 
yearly [18]. However, in our study, 59.1% of males and 
40.9% of females reported migraine headaches. Our 
study reported higher migraine prevalence because it 
was conducted in a developing country with a 
significant percentage of the population living below 
poverty with greater depression rates.
   
Migraine significantly affects the functional capacity of 
an individual making most of the daily tasks impossible 
to perform. Published literature reports that migraine is 
also negatively associated with years of schooling and 
grades. Migraine makes it difficult to maintain regular 
attendance and concentrate on studies. Students with 
migraine headaches are often forced to miss school 
and even if they attend school, their productivity is 
remarkably reduced. It increases the cost of remaining 
in school to the extent that it hinders learning, it can be 
considered as reducing the returns to remain in school 
[14, 20, 21].
 
Our study provides the hindsight that depression is as 
common among migraine sufferers as patients 
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suffering from other chronic diseases. The frequency of 
depression among migraine subjects was observed to 
be 74.2%. Wang et al in a study comprising subjects 
over 65 years reported that the risk of current 
depression was greater in migraine than in 
non-migraine patients [22]. Merikangas et al. in their 
study comprising 457 younger subjects reported an 
increased risk of developing major depression and 
anxiety disorders compared with controls [23]. A 
population-based case-control study conducted by 
Lipton et al. confirmed a higher risk of current 
depression among patients suffering from migraines 
[14]. Swartz et al. studied psychiatric illnesses as 
possible risk factors for migraine onset with a 
prospective follow-up of 13 years and demonstrated 
that only a history of phobic disorder predicted migraine 
onset [24].
Jelinski et al. reported that certain clinical and 
demographic factors are independently associated with 
depression in a population of patients with headaches. 
These factors included younger age and 
unemployment, obtaining financial support through 
disability pension or welfare, and being divorced, 
separated, or widowed [25]. In contrast, stratification 
analysis in our study demonstrated that the rate of 
depression was not significantly associated with 
monthly income, educational status, occupation. 
Monthly income was used as a parameter to measure 
the socio-economic status of the participants.
However, some limitations of our study must be 
considered. Our study comprised of small sample size, 
and recruited migraine subjects from only a single 
tertiary care center, which limits the generalizability of 
our results. Bipolar disorder was not identified in our 
sample population but can be a cause of depression in 
a general population. These limitations should be taken 
into consideration when extrapolating our results to 
other migraine subjects. Nonetheless, we feel that the 
results observed in this small sample provide a platform 
for further investigations into the interaction between 
migraine and depression by including a large sample 
population from primary care settings that serve a 
variety of ethnic populations.
CONCLUSION
In conclusion, migraine is consistently related to 
depression. This association can have several 
important clinical implications as the prevalence of 
depression was found to be significantly high among 
migraine patients. For good prognosis and 
management of the disease, physicians should 
evaluate for the presence of depression among 
migraine subjects, both the disorders should be taken 
into account when formulating an effective treatment 
plan. Treatment of one disorder can prevent further 
progression to one or both of them and result in a good 
prognosis. A suitable therapeutic approach among 
migraine subjects can reduce the disability burden 
among these subjects, hence reducing health-care 
resources and economic burden.
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